Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 450 Stomach Neoplasms 295 Rectal Neoplasms 271 Colonic Neoplasms 192 Pancreatic Neoplasms 177 Neoplasm Metastasis 94 Esophageal Neoplasms 88 Carcinoma, Hepatocellular 60 Adenocarcinoma Of Esophagus 47 Cholangiocarcinoma 46 Neoplasms 42 Biliary Tract Neoplasms 38 Gallbladder Neoplasms 31 Adenocarcinoma 30 Gastrointestinal Neoplasms 29 Liver Neoplasms 25 Esophageal Squamous Cell Carcinoma 23 Carcinoma, Non-Small-Cell Lung 18 Bile Duct Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Locally Advanced Rectal Cancer 13 Colorectal Cancer Metastatic 11 Appendiceal Neoplasms 11 Recurrence 10 Peritoneal Neoplasms 10 Ovarian Neoplasms 9 Carcinoma 7 Breast Neoplasms 7 Neurotoxicity Syndromes 6 Gastrointestinal Diseases 6

Interventions

Diathermy 6 Fluorouracil 4 Radiotherapy 3 Melphalan 2 Drug Therapy 2 Capecitabine 2 tislelizumab 1 spartalizumab 1 Radiation 1 Oxaliplatin 1 Mitomycin 1 Leucovorin 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Folfox protocol 1 Floxuridine 1 Cytoreduction Surgical Procedures 1 Control Groups 1 Consolidation Chemotherapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Oxaliplatin × Gastrointestinal × Clear all

NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡